Dysfunction of the autonomic nervous system in dogs (Dysautonomia, Key-Gaskell Syndrome)
- Occurrence: very rare
- Location of disease: General/Whole body
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Dysautonomia of the autonomic nervous system, also known as Key-Gaskell syndrome, is a rare but serious neurological disease in dogs characterized by a malfunction or damage to the autonomic nervous system, which controls the unconscious regulation of internal organs.
The most important facts at a glance
Dysautonomia of the autonomic nervous system, also known as Key-Gaskell syndrome, is a rare neurological disease in dogs that affects the autonomic nervous system, which controls involuntary bodily functions such as heartbeat, digestion, and breathing. The exact causes are unclear, but environmental factors, genetic predispositions, toxic exposures, or infectious agents could play a role. Symptoms include problems with defecation and urination, abdominal pain, low heart rate, dry eyes and nose, dilated pupils, vomiting, weakness, and loss of appetite. The diagnosis is based on clinical symptoms and specific tests such as the Schirmer tear test and ECG. Imaging procedures can help rule out other diseases. A biopsy of nerve structures may be necessary in some cases. There is no specific cure; treatment focuses on symptomatic relief, such as administering artificial tears and dietary adjustments. The prognosis is often unfavorable, as the disease is progressive. Prevention is difficult since the exact causes are unclear, but a healthy environment and regular veterinary examinations can be helpful. Research focuses on genetic and environmental factors to understand the pathophysiology and identify biomarkers for early diagnosis. Advances could lead to better treatment options and preventive strategies.
Causes
The autonomic nervous system is part of the peripheral nervous system responsible for regulating vital functions such as heart rate, digestion, respiratory rate, salivation, tear production, pupil size, bladder emptying, and sexual arousal. It consists of two main components: the sympathetic nervous system, which controls the “fight-or-flight” mechanism, and the parasympathetic nervous system, which supports the “rest-and-digest” mechanism.
Dysautonomia occurs when there is a malfunction in these autonomic pathways. The exact causes of dysautonomia are not yet fully understood, but it is believed that environmental factors, genetic predispositions, toxic exposures, or infectious agents could play a role. According to some reports, there are geographic clusters, which could indicate a possible environmental factor. Further research is necessary to fully decipher the etiology.
Regarding pathophysiology, there is a degeneration of the neuronal structures that control the autonomic nervous system. This degeneration can affect both the sympathetic and parasympathetic parts, leading to a variety of systemic symptoms. It is important to note that both central and peripheral parts of the autonomic nervous system can be affected.
Symptoms
- Lethargy
- Decreased Pupillary Light Reflex
- Lack of Tear Production
- Prolapsed third eyelid (nictitating membrane)
- Regurgitation of undigested food
- General condition impaired
- Inappropriate Urination (House Soiling)
- Uncontrolled Urination (Urinary Incontinence)
- Uncontrolled Defecation (Fecal Incontinence)
- Difficulty Urinating (Dysuria)
- Inability to Defecate
- Defecation Difficulties
- Abdominal Tenderness
- Bauchschmerzen
- Dysphagia (difficulty swallowing)
- Ptosis of the upper eyelid
The clinical symptoms of dysautonomia are diverse and can vary depending on the severity of the disease. Common symptoms include dilated pupils that do not respond to light (mydriasis), dry mucous membranes due to reduced saliva and tear production, and difficulty swallowing, which can lead to regurgitation.
Other signs include altered heart rate, often bradycardia, as well as gastrointestinal problems such as vomiting, diarrhea, or constipation. Some dogs also show bladder dysfunction, which can lead to incontinence or difficulty urinating. Weight loss and loss of appetite are also common symptoms, caused by impaired digestion and food intake.
In severe cases, dogs may show signs of weakness or collapse, indicating inadequate circulatory regulation. Changes in the autonomic nervous system also lead to a reduced ability to respond to stress, which further complicates the disease.
Therapy
Unfortunately, there is no specific cure for dysautonomia of the autonomic nervous system in dogs. Treatment focuses on symptomatic relief and support of the affected functions. This may include the administration of artificial tears to treat dry eyes and medications to regulate heart rate.
Dietary adjustments may be necessary to support digestion, and medications to promote gastrointestinal motility may be used if needed. In some cases, supportive fluid administration may be required to ensure fluid balance.
Caring for affected dogs often requires intensive care to maintain quality of life, as the disease is progressive and potentially life-threatening.
Prognosis and follow-up care
The prognosis for dogs with dysautonomia of the autonomic nervous system is generally unfavorable. The disease is often progressive, and many dogs experience a worsening of symptoms despite treatment. In some cases, sudden death can occur, especially when cardiovascular regulation is severely impaired.
Some dogs can maintain a certain quality of life with intensive support and management, but life expectancy is usually shortened. Early diagnosis and interventional measures can help slow the progression and relieve symptoms, but complete recovery is rare.
Prevention
Since the exact causes of dysautonomia are not fully understood, there are no specific prevention measures. However, it is recommended to minimize exposure to potentially toxic substances and to ensure a healthy environment for dogs.
Regular veterinary check-ups can help to detect and treat health problems early. A balanced diet and sufficient exercise also contribute to general health and resilience against diseases.
For dogs in areas where the disease occurs more frequently, close monitoring and proactive health care could be useful. Research to identify specific environmental factors or genetic markers could lead to more targeted prevention strategies in the future.
Outlook on current research
Dysautonomia of the autonomic nervous system in dogs, also known as Key-Gaskell syndrome, is a rare but serious neurological disease that affects the autonomic nervous system. This system controls involuntary bodily functions such as heartbeat, digestion, and breathing. Despite its rarity, this disease has attracted research interest in recent years, as understanding it could provide insights into similar diseases in other animal species and in humans. Current studies focus on identifying genetic and environmental factors that could contribute to the development of this disease. Furthermore, research is being conducted to determine whether certain breeds are more susceptible and what preventive measures could be taken.
A key aspect of research is the investigation of the pathophysiology of this disease to understand the exact mechanisms that lead to dysfunction of the autonomic nervous system. Researchers are working to identify biomarkers that could enable early diagnosis. This is particularly important because early detection of the disease could lead to better treatment outcomes. Veterinary neurologists and researchers use advanced imaging techniques such as MRI and CT to identify changes in nerve tissue that could indicate dysautonomia.
Another area of research focuses on developing therapeutic approaches to treat the symptoms associated with this disease. Currently, there is no specific cure for dysautonomia, and treatment consists mainly of supportive care to relieve symptoms. Research into pharmacological interventions that specifically support the autonomic nervous system could offer new treatment options in the future. Furthermore, research is being conducted to determine whether physiotherapeutic measures or dietary adjustments could have a positive influence on the course of the disease.
Research into Key-Gaskell syndrome could also have implications for human medicine, particularly regarding diseases such as autonomic nervous system failure in humans. Interdisciplinary collaboration between veterinary and human medicine could produce new insights and treatment strategies that benefit both fields. Genetic investigation of dogs with dysautonomia could also lead to a better understanding of genetic predispositions in humans.
In the long term, researchers hope that through their work they can not only improve understanding and treatment options for dysautonomia, but also raise awareness of this rare disease. Public outreach and education are crucial to inform pet owners and veterinarians and to increase the chances of early detection and treatment. Advances in research could lead to more precise diagnostic tools and more effective therapies becoming available in the near future.
Frequently Asked Questions (FAQs)
1. What is dysautonomia of the autonomic nervous system in dogs?
2. Which dogs are most commonly affected?
3. What Symptoms occur in affected dogs?
4. How is the diagnosis made?
5. Is there a cure for dysautonomia?
6. Can preventive measures be taken?
7. What is the prognosis for dogs with dysautonomia?
8. What support is available for dog owners?
9. Is dysautonomia in dogs comparable to human diseases?
10. What should dog owners do if they notice symptoms in their pet?
Literature
- Atkins, C. N., Hahn, C. N., & McGorum, B. C. (2025). Comparison of dysautonomia across species: Current knowledge and future research opportunities. Journal of Veterinary Internal Medicine, 39(4), e70140. https://doi.org/10.1111/jvim.70140
- Clarke, K. E., Sorrell, S., Breheny, C., Jepson, R. E., Adamantos, S., Milne, E. M., & Gunn-Moore, D. (2020). Dysautonomia in 53 cats and dogs: Retrospective review of clinical data and outcome. Veterinary Record, 187(12), e118. https://doi.org/10.1136/vr.105258
- Harkin, K. R., Andrews, G. A., & Nietfeld, J. C. (2002). Dysautonomia in dogs: 65 cases (1993–2000). Journal of the American Veterinary Medical Association, 220(5), 633–639. https://doi.org/10.2460/javma.2002.220.633
- Longshore, R. C., O’Brien, D. P., Johnson, G. C., Grooters, A. M., & Kroll, R. A. (1996). Dysautonomia in dogs: A retrospective study. Journal of Veterinary Internal Medicine, 10(3), 103–109. https://doi.org/10.1111/j.1939-1676.1996.tb02040.x
- Berghaus, R. D., O’Brien, D. P., Johnson, G. C., & Thorne, J. G. (2001). Risk factors for development of dysautonomia in dogs. Journal of the American Veterinary Medical Association, 218(8), 1285–1290. https://doi.org/10.2460/javma.2001.218.1285
- Berghaus, R. D., O’Brien, D. P., Thorne, J. G., & Buening, G. M. (2002). Incidence of canine dysautonomia in Missouri, USA, between January 1996 and December 2000. Preventive Veterinary Medicine, 54(4), 291–300. https://doi.org/10.1016/S0167-5877(02)00030-2
- Detweiler, D. A., Biller, D. S., Hoskinson, J. J., & Harkin, K. R. (2001). Radiographic findings of canine dysautonomia in twenty-four dogs. Veterinary Radiology & Ultrasound, 42(2), 108–112. https://doi.org/10.1111/j.1740-8261.2001.tb00912.x
- Niessen, S. J. M., Eastwood, J., Smyth, J. B. A., & Cherubini, G. B. (2007). Five cases of canine dysautonomia in England (2004 to 2006). Journal of Small Animal Practice, 48(6), 346–352. https://doi.org/10.1111/j.1748-5827.2006.00263.x
- Pollin, M., & Sullivan, M. (1986). A canine dysautonomia resembling the Key-Gaskell syndrome. Veterinary Record, 118(14), 402–403. https://doi.org/10.1136/vr.118.14.402
- Schulze, C., Schanen, H., & Pohlenz, J. (1997). Canine dysautonomia resembling the Key-Gaskell syndrome in Germany. Veterinary Record, 141(19), 496–497. https://doi.org/10.1136/vr.141.19.496